Evidence map›Paper›PMID 35666067›Full record

ArticleFEBS open bio2022

N-Acetylcysteine protects against cobalt chloride-induced endothelial dysfunction by enhancing glucose-6-phosphate dehydrogenase activity.

Chen Yang, Xiaofang Zhang, Xilin Ge, Chunmei He, Suhuan Liu, Shuyu Yang, Caoxin Huang

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chen YangDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Xiaofang ZhangDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Xilin GeDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Chunmei HeDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Suhuan LiuDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Shuyu YangDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Caoxin HuangDepartment of Endocrinology and Diabetes, Xiamen Diabetes Institute, Fujian Key Laboratory of Translational Research for Diabetes,The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.ORCID 0000-0002-9452-8724
First Affiliated Hospital of Xiamen University · CNNanjing General Hospital of Nanjing Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia-induced endothelial dysfunction is known to be involved in the pathogenesis of several vascular diseases. However, it remains unclear whether the pentose phosphate pathway (PPP) is involved in regulating the response of endothelial cells to hypoxia. Here, we established an in vitro model by treating EA.hy926 (a hybrid human umbilical vein cell line) with cobalt chloride (CoCl

Indexed as

AcetylcysteineVascular DiseasesCobaltGlucosephosphate DehydrogenaseHumansHuman Umbilical Vein Endothelial CellsHypoxiaAcetylcysteineCobaltcobaltous chlorideGlucosephosphate Dehydrogenaseendothelial cellsglucose-6-phosphate dehydrogenasehypoxiaN-Acetylcysteinepentose phosphate pathway

Identifiers

PMID35666067
PMCPMC9340863
OpenAlexW4281632090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.